List of Kinevac drug patents

Kinevac is owned by Bracco.

Kinevac contains Sincalide.

Kinevac has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Kinevac are:

  • US6803046

Kinevac is available in injectable;injection dosage forms.

The generics of Kinevac are possible to be released after 16 August, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6803046 BRACCO Sincalide formulations
Aug, 2022

(5 months ago)

Drugs and Companies using SINCALIDE ingredient

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in